Literature DB >> 9558731

Beneficial effects of cytokine induced hyperlipidemia.

K R Feingold1, I Hardardóttir, C Grunfeld.   

Abstract

Infection, inflammation and trauma induce marked changes in the plasma levels of a wide variety of proteins (acute phase response), and these changes are mediated by cytokines. The acute phase response is thought to be beneficial to the host. The host's response to injury also results in dramatic alterations in lipid metabolism and circulating lipoprotein levels which are mediated by cytokines. A large number of cytokines including TNF, the interleukins, and the interferons increase serum triglyceride levels. This rapid increase (1-2 h) is predominantly due to an increase in hepatic VLDL secretion while the late increase may be due to a variety of factors including increased hepatic production of VLDL or delayed clearance secondary to a decrease in lipoprotein lipase activity and/or apolipoprotein E levels on VLDL. In animals other than primates, cytokines also increase serum cholesterol levels, most likely by increasing hepatic cholesterol. Cytokines increase hepatic cholesterol synthesis by stimulating HMG CoA reductase gene expression and decrease hepatic cholesterol catabolism by inhibiting cholesterol 7 alpha-hydroxylase, the key enzyme in bile acid synthesis. Injury and/or cytokines also decrease HDL cholesterol levels and induce alterations in the composition of HDL. The content of SAA and apolipoprotein J increase, apolipoprotein A1 may decrease, and the cholesterol ester content decreases while free cholesterol increases. Additionally, key proteins involved in HDL metabolism are altered by cytokines; LCAT activity, hepatic lipase activity, and CETP levels decrease. These changes in lipid and lipoprotein metabolism may be beneficial in a number of ways including: lipoproteins competing with viruses for cellular receptors, apolipoproteins neutralizing viruses, lipoproteins binding and targeting parasites for destruction, apolipoproteins lysing parasites, redistribution of nutrients to cells involved in the immune response and/or tissue repair, and lipoproteins binding toxic agents and neutralizing their harmful effects. Thus, cytokines induce marked changes in lipid metabolism that lead to hyperlipidemia which represents part of the innate immune response and may be beneficial to the host.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558731

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  10 in total

Review 1.  A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.

Authors:  Eduardo Nicolas Pollono; Maria A Lopez-Olivo; Juan Antonio Martinez Lopez; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

2.  IL-1β, IL-6, IL-8, IL-10, IFN-γ, TNF-α and its relationship with lipid parameters in patients with major depression.

Authors:  Cicek Hocaoglu; Birgul Kural; Rezzan Aliyazıcıoglu; Orhan Deger; Sevil Cengiz
Journal:  Metab Brain Dis       Date:  2012-06-19       Impact factor: 3.584

3.  Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

Authors:  Irene F Gazi; Fotini A Apostolou; Evangelos N Liberopoulos; Theodosios D Filippatos; Constantinos C Tellis; Moses S Elisaf; Alexandros D Tselepis
Journal:  Lipids       Date:  2011-06-19       Impact factor: 1.880

Review 4.  Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver.

Authors:  Jinyao Liu
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Authors:  Calin Popa; Frank H J van den Hoogen; Timothy R D J Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; Piet L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

6.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

7.  Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

Authors:  Iris Navarro-Millán; Christina Charles-Schoeman; Shuo Yang; Joan M Bathon; S Louis Bridges; Lang Chen; Stacey S Cofield; Louis J Dell'Italia; Larry W Moreland; James R O'Dell; Harold E Paulus; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2013-06

8.  The effect of Aloe vera leaf gel on fatty streak formation in hypercholesterolemic rabbits.

Authors:  Nasim Dana; Shaghayegh Haghjooy Javanmard; Sedigheh Asgary; Hossein Asnaashari; Narges Abdian
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

9.  Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis.

Authors:  Emilio-Manuel Páez-Guillán; Joaquín Campos-Franco; Rosario Alende; Yago Garitaonaindía; Arturo González-Quintela
Journal:  Lipids Health Dis       Date:  2021-12-12       Impact factor: 3.876

10.  Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

Authors:  Anita K McElroy; Punya Shrivastava-Ranjan; Jessica R Harmon; Roosecelis B Martines; Luciana Silva-Flannery; Timothy D Flietstra; Colleen S Kraft; Aneesh K Mehta; G Marshall Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Sherif R Zaki; Christina F Spiropoulou
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.